A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
Detection Principle
ImmunoAssay-Antibody
Target
Ab
Testing Method Category
Other Immuno assay
Testing Method
fluorescence-based high-throughput neutralization assay
Testing Method - Additional Info
The assay was built on a stable mNeonGreen (mNG) SARS-CoV-2 where the mNG gene was engineered at the ORF7 of the viral genome
Reported Performance
Remark: NT50 values comparable to the conventional PRNT assay
Sample Size
120 samples (clinical evaluation), 150 samples (cross reactivity)
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements